Beta-Lactone Synthetase Pocket Engineering for Short Alkyl Tail Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Traditional chemical catalysis struggles to synthesize beta-lactones with short alkyl tails, which are preferred for PHA synthesis due to their suitability and reactivity, as naturally occurring beta-lactone synthetases favor bulky, long alkyl tail substrates.

Innovation Solution

A two-step bioconversion process using a recombinant microorganism to produce 3-hydroxycarboxylic acids with C1-C10 alkyl groups, followed by reaction with a bioengineered beta-lactone synthetase having a substrate binding pocket for short alkyl tail beta-lactone synthesis, facilitating the production of biodegradable PHAs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If naturally occurring beta-lactone synthetases are used, then beta-lactones with long alkyl tails are produced, but these are unsuitable for PHA synthesis

Engineering Contradiction:
Improvesuitability for PHA synthesisVSAvoidalkyl tail length
Core Design Contradiction:
ReliabilityVSLength of moving object

Solution Approach 1:

The patent applies parameter changes by modifying the substrate binding pocket of beta-lactone synthetase through site-directed mutagenesis. Specific amino acid residues (e.g., Phe164, Leu165, Ile166 in the omega loop region) are mutated to create a smaller binding pocket that accommodates short alkyl tail substrates (C1-C10) instead of the natural long alkyl tail substrates, thereby producing beta-lactones suitable for PHA synthesis

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses an engineered intermediate enzyme form - a bioengineered beta-lactone synthetase with modified substrate binding pocket - as an intermediary between the natural enzyme and the desired short alkyl tail beta-lactone product. This engineered enzyme serves as a mediator that redirects the natural enzymatic pathway to produce the required short-chain substrates for PHA synthesis

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If traditional chemical catalysis is used, then synthesis of beta-lactones is attempted, but it is challenging due to ring structure constraints

Engineering Contradiction:
Improvesynthesis feasibilityVSAvoidsynthesis process complexity
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

The patent replaces traditional chemical catalysis (mechanical/chemical system) with enzymatic catalysis using bioengineered beta-lactone synthetase. This substitution leverages the specificity and efficiency of biological catalysts to overcome the challenges of synthesizing four-membered heterocyclic ring structures, which are difficult to form through conventional chemical methods due to ring strain and stereochemical constraints

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the catalytic mechanism from chemical to biological by engineering the enzyme's substrate binding pocket. This parameter change in the catalytic system enables selective production of short alkyl tail beta-lactones that are difficult to obtain through traditional chemical synthesis, simplifying the overall manufacturing process for PHA precursors

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables the de novo biosynthesis of short alkyl tail beta-lactones with high ring-strain, enhancing their reactivity and suitability for PHA synthesis by avoiding the limitations of long alkyl tail beta-lactones, thereby improving the properties and crystallinity of the resulting biodegradable PHAs.

Implementation Method 1

reacting a feedstock and a recombinant microorganism harboring one or more genes encoding enzymes involved in a metabolic pathway of a 3-hydroxycarboxylic acid synthesis

Methodology Applied
Scientific EffectBioconversion: Fermentation

Implementation Method 2

harboring one or more genes encoding enzymes involved in a metabolic pathway of a 3-hydroxycarboxylic acid synthesis

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 3

reacting the 3-hydroxycarboxilic acid with a bioengineered natural beta-lactone synthetase, the bioengineered beta-lactone synthetase engineered to comprise a substrate binding pocket capable of accepting the 3-hydroxycarboxylic acid

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 4

the bioengineered natural beta-lactone synthetase engineered to comprise a substrate binding pocket capable of accepting the 3-hydroxycarboxylic acid having C1-C10 alkyl groups

Methodology Applied
Scientific EffectBioengineering:

Data Source

PatentUS20240191265A1Beta-Lactone Production Through Bioconversion and Methods Related Thereto
Publication Date: 2024.06.13 EXXONMOBIL TECHNOLOGY & ENGINEERING CO
  • US20240191265A1 patent drawing
  • US20240191265A1 patent drawing
  • US20240191265A1 patent drawing

AI summary

Methods of β-lactone production, including the integrated bioconversion of β-lactone production and methods related thereto. Methods include reacting a feedstock and a recombinant microorganism harboring one or more genes encoding enzymes involved in the metabolic pathway of a 3-hydroxycarboxylic acid, thereby producing a 3-hydroxycarboxylic acid having C1-C10 alkyl groups. Thereafter, reacting the 3-hydroxycarboxilic acid with a bioengineered natural β-lactone synthetase, the bioengineered β-lactone synthetase engineered to comprise a substrate binding pocket capable of accepting the 3-hydroxycarboxylic acid having C1-C10 alkyl groups, thereby producing a β-lactone having C1-C10 alkyl groups.